The response to the previous editions of this text have been favourable, and it has clearly fulfilled a need of target audience. Since the last edition the important changes that have transformed pharmacotherapy are the rise of evidence based medicine (EBM) and the firm establishment of national and international therapeutic guidelines, usually based on careful meta-analyses of randomized controlled trials. These have frequently been issued by disease specific organizations such as the British Hypertension Society, or generic bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Prescribing Centre in the UK.
These guidelines have been incorporated into this edition wherever available, and have been a main focus of the update. However, as before, the overall intention remains to demonstrate how knowledge of the biomedical sciences of physiology, pathology and pharmacology underpins understanding of the rationale behind these recommendations.
The new edition will be as useful as the first two evidently have, and that it will continue to interest practitioners of disciplines outside the confines of pharmacy, reflecting the multidisciplinary nature of modern healthcare.
New to this edition
- significantly reorganized and harmonized the sections and headings to improve consistency in structure and comprehension. These changes, together with a more detailed index, have enabled us to use an improved internal cross-referencing system.
- Where there are crossreferences within a chapter, the reader is directed to a closely-associated block of text or, if the reference is more remote, the page number is given.
- Cross-references outside a chapter give the chapter number, which together with the index should enable the material to be located quickly.
- Coverage of Thyroid disease in the Endocrine chapter have been added.
- A new chapter on Haematological disease.
- The use of drugs in renal impairment has been expanded in the Renal chapter.
- Evidence based therapeutic guidelines have been emphasized throughout.
- The References and further reading lists have been updated and rINNs are used throughout for drug nomenclature, following the BNF wherever possible.
Contents
- Dedication and acknowledgements
- with a note on drug nomenclature
- Preface to the third edition
- Extract from preface to the first edition
- About the authors
- Recommended reference sources
- Abbreviations
- Plate section between pages 854 and
PART 1 Basic strategy and introduction to pathology
1 Therapeutics: general strategy
- Terminology of disease
- Case history
- Drug disposition
- Drug selection
- References and further reading
2 Major pathological processes in disease
- Introduction
- Immunology
- Inflammation
- Ischaemia
PART 2 Body systems and their principal diseases
- 3 Gastrointestinal and liver diseases
- 4 Cardiovascular system
- 5 Respiratory diseases
- 6 Central nervous system
- 7 Pain and its treatment
- 8 Infections and antimicrobial therapy
- 9 Endocrine system
- 10 Neoplastic disease
- 11 Haematology
- 12 Rheumatology: musculoskeletal and connective tissue diseases
- 13 Skin diseases
- 14 Renal system
Index
About the Editors
Russell J. Greene, BPharm MSc PhD MRPharmS, Senior Lecturer in Clinical Pharmacy, Former Head, Pharmacy Practice Group, Department of Pharmacy, King’s College London, University of London, UK.
Dr Russell Greene gained his BPharm from Nottingham University in 1967 and did his pre-reg in Elizabeth Garrett Anderson hospital in London.
After working in hospital and community pharmacy in the UK and abroad he gained an MSc by research from Bath University in 1973 for a thesis on Drug administration in psychiatric hospitals.
Following a further spell abroad, including a year setting up a pharmacy training course at the University of the South Pacific in Fiji, in 1978 he became the Principal pharmacist for Education and training for the NWThames Regional Health Authority.
He joined Chelsea College in 1980 to teach clinical pharmacy and moved with it to King’s College in 1987. He gained his PhD in 1993 for a thesis on Prescription monitoring by community pharmacists and the role of medication records. He became senior lecturer in 1995 and
head of the Pharmacy Practice group in 1998. He was the MPharm Programme director until 2006, and his principal teaching responsibility has been organizing courses in pathology and therapeutics.
Norman D. Harris, BPharm PhD DIC, Emeritus Reader in Pharmaceutics, Department of Pharmacy, King’s College London, University of London, UK.
Dr Norman Harris entered Pharmacy in 1947 following National Service, having been an industrial chemist in metal processing and the food industry.
As apprentice at a very traditional London pharmacy, which dispensed for nearby embassies, he learned full-range extemporaneous dispensing, including suppositories, pessaries and silvered pills from prescriptions written in 1910!
At Chelsea School of Pharmacy he acquired the Chemist and Druggist and Pharmaceutical Chemist Diplomas, a BPharm degree, and won the Pharmaceutical Society’s Pereira Medal. A spell at Imperial College led to a PhD in Microbiology and the Imperial College Diploma and Fellowship of the Pharmaceutical Society followed in 1954.
On the staff at Chelsea, he taught Pharmacognosy (briefly), Pharmaceutics (Dispensing, Microbiology, Radiopharmacy), becoming Reader in Pharmaceutics and Head of Clinical Pharmacy, Honorary Pharmacist at Hammersmith Hospital and Chairman of the Oxford Region Pharmacy Advisory Committee. He was Post-graduate Tutor for the North-West Thames Region for many years and retired in 1984.
Product Details
- Paperback: 982 pages
- Publisher: Pharmaceutical Press; 3 edition (February 28, 2008)
- Language: English
- ISBN-10: 085369690X
- ISBN-13: 978-0853696902
- Product Dimensions: 9.7 x 7.5 x 2 inches
List Price: $82.50